American Oncology Network, Inc.
AONC · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $491 | $470 | $434 | $364 |
| % Growth | 4.4% | 8.4% | 19.1% | – |
| Cost of Goods Sold | $448 | $434 | $405 | $355 |
| Gross Profit | $43 | $37 | $29 | $9 |
| % Margin | 8.7% | 7.8% | 6.8% | 2.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $34 | $35 | $37 | $28 |
| SG&A Expenses | $34 | $35 | $37 | $28 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $1 | $0 |
| Operating Expenses | $34 | $35 | $37 | $29 |
| Operating Income | $8 | $2 | -$8 | -$19 |
| % Margin | 1.7% | 0.3% | -1.8% | -5.3% |
| Other Income/Exp. Net | -$6 | -$3 | $5 | -$3 |
| Pre-Tax Income | $2 | -$2 | -$3 | -$22 |
| Tax Expense | -$0 | -$0 | -$0 | $3 |
| Net Income | $1 | -$1 | $4 | -$8 |
| % Margin | 0.3% | -0.2% | 0.8% | -2.2% |
| EPS | -0.003 | -0.19 | 0.12 | -1.22 |
| % Growth | 98.7% | -258.3% | 109.8% | – |
| EPS Diluted | -0.003 | -0.19 | 0.038 | -1.22 |
| Weighted Avg Shares Out | 13 | 13 | 11 | 8 |
| Weighted Avg Shares Out Dil | 13 | 13 | 10 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $2 | $2 | $2 | $2 |
| Depreciation & Amortization | $6 | $5 | $5 | $5 |
| EBITDA | $9 | $5 | $3 | -$16 |
| % Margin | 1.9% | 1.1% | 0.7% | -4.3% |